Bi-Specific Cancer Treatment Constructs with Different Epitope Binding

Thu, 16 Apr 2026 08:37:38 +0000
Intellectual Property

The European Patent Office published patent application EP3484516A1 assigned to Fred Hutchinson Cancer Center on April 8, 2026. The patent covers bi-specific binding domain constructs with different epitope binding properties for treating cancer. The technology falls under IPC classifications A61K 39/395, C07K 16/28, and C12N 15/09, with designated states covering major European markets.